Lenzing's €300 Million Raise Is Fully Underwritten — Berenberg's Downgrade Is About Something Else Entirely
Published on 10/19/2026 at 19:40 | Editorial boerse-global.deLenzing has two clocks ticking at once, and they measure different things. One is a financing calendar that ends on October 20. The other is an earnings question that no subscription deadline can settle. Investors who blur the two risk mistaking a well-guaranteed capital increase for proof that the business is turning.
The fully underwritten rights issue, announced roughly two weeks ago, targets a gross proceeds figure of about EUR 300 million. It will issue 34,756,362 new shares at EUR 8.65 apiece, on a 10:9 subscription ratio. The offer is scheduled to close on October 20, with delivery and the start of trading in the new shares expected on October 23, subject to registration of the capital increase in the commercial register. Those dates are firm; the trading debut remains conditional rather than completed.
A Balance-Sheet Fix, Not an Earnings Signal
What the guarantee does not do is say anything about future profit. The underwriting assures the money arrives; it says nothing about whether higher cotton and viscose prices are reaching the bottom line. That gap is precisely where Berenberg aimed its criticism, also about two weeks ago, cutting its rating from "Buy" to "Hold" and slashing the price target to EUR 17.00 from EUR 29.50. The broker's core argument was operational: elevated raw-material prices had failed to flow through to results. It also flagged doubts about support from majority shareholder Suzano in connection with the raise.
Shareholder filings paint a mixed picture of their own. Georg Kasperkovitz exercised subscription rights a little over a week ago. NN Group, by contrast, reported crossing below a threshold, with its voting stake at 2.54% following 6.27% in the prior disclosure. Neither a board member's exercise nor an institution's reduced holding answers the operating question on its own.
Should investors sell immediately? Or is it worth buying Lenzing?
Denim as a Test Case, Not a Verdict
On the product side, Lenzing unveiled the REMOD collection with Japanese denim maker Kaihara, built around TENCEL Lyocell Standard and HV100. In parallel, the company expanded its network of TENCEL Lyocell HV100 partner mills to nearly 50 weavers across 13 countries. That reach offers a concrete place to watch for take-up — a reference application that could seed further demand and business relationships.
Scale, though, is not the same as commercial success. A broader network guarantees neither usage nor orders, and the collection could draw attention without generating economically meaningful demand. The bull case requires the collaboration to convert into additional demand and earnings contributions; that is a condition, not a consequence of the launch.
The Dilution Arithmetic
New shares also mean a larger share count, so fresh capital alone does not settle what happens to earnings per share down the road. The real hazard is treating the financing and the product presentation together as sufficient evidence of an operational turnaround. Only actual business performance can support that conclusion.
Lenzing at a turning point? This analysis reveals what investors need to know now.
The next hard checkpoint is the announced third-quarter 2026 report, when business development moves back ahead of product marketing. Until the initiative translates into genuine economic use, the positive scenario stays plausible but unproven — and network size by itself will not carry a re-rating.
Ad
Lenzing Stock: New Analysis - 19 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
